Variant report
Variant | nsv818331 |
---|---|
Chromosome Location | chr5:27510050-27526060 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C5orf17-14 | chr5:27511399-27511559 | ucscGeneNc_uc003jgv_1 |
2 | lnc-C5orf17-14 | chr5:27520790-27521692 | ucscGeneNc_uc003jgv_1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147614072 | chr5:27510208-27510209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537943155 | chr5:27510225-27510226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550946629 | chr5:27510231-27510232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566602698 | chr5:27510296-27510297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532730852 | chr5:27510398-27510399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557861743 | chr5:27510399-27510400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566266088 | chr5:27510411-27510412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34504792 | chr5:27510423-27510424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144528571 | chr5:27510424-27510425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200268796 | chr5:27510425-27510426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs70942430 | chr5:27510427-27510428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs72731319 | chr5:27510428-27510429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201285645 | chr5:27510440-27510441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs199796436 | chr5:27510441-27510442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75394603 | chr5:27510450-27510451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555583337 | chr5:27510507-27510508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374343327 | chr5:27510539-27510540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182432002 | chr5:27510558-27510559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs68126497 | chr5:27510584-27510585 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs188323629 | chr5:27510600-27510601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs114863387 | chr5:27511219-27511220 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537771900 | chr5:27511234-27511235 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs35230078 | chr5:27511250-27511251 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573010097 | chr5:27511337-27511338 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542156187 | chr5:27511342-27511343 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs149129648 | chr5:27511363-27511364 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537617914 | chr5:27511366-27511367 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143399078 | chr5:27511370-27511371 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575430458 | chr5:27511421-27511422 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs571597547 | chr5:27511472-27511473 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs538923696 | chr5:27511489-27511490 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs558227554 | chr5:27511551-27511552 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs545949352 | chr5:27520817-27520818 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs117506637 | chr5:27520875-27520876 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs573072919 | chr5:27520909-27520910 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs534743880 | chr5:27520940-27520941 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs2329622 | chr5:27520955-27520956 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs559467034 | chr5:27520963-27520964 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs574989323 | chr5:27520964-27520965 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs533436969 | chr5:27520976-27520977 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs76833470 | chr5:27521067-27521068 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs35907554 | chr5:27521073-27521074 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs146169055 | chr5:27521102-27521103 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs563886439 | chr5:27521104-27521105 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs73071700 | chr5:27521109-27521110 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs367681788 | chr5:27521121-27521122 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs546354824 | chr5:27521145-27521146 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs138980266 | chr5:27521168-27521169 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs187926291 | chr5:27521187-27521188 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs546323639 | chr5:27521209-27521210 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:27510200-27510600 | Enhancers | Liver | Liver |
2 | chr5:27510400-27510600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr5:27511200-27511600 | Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr5:27511200-27511600 | Enhancers | Hela-S3 | cervix |
5 | chr5:27511200-27511600 | Active TSS | Osteobl | bone |
6 | chr5:27511400-27511600 | Enhancers | Fetal Kidney | kidney |
7 | chr5:27523600-27524000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr5:27523800-27524000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |